Abstract
Molecular epidemiological association studies use valuable biosamples and incur costs. Statistical methods for early genotyping termination may conserve biosamples and costs. Group sequential methods (GSM) allow early termination of studies on the basis of interim comparisons. Simulation studies evaluated the application of GSM using data from a case-control study of GST genotypes and prostate cancer. Group sequential boundaries (GSB) were defined in the EAST-2000 software and were evaluated for study termination when early evidence suggested that the null hypothesis of no association between genotype and disease was unlikely to be rejected. Early termination of GSTM1 genotyping, which demonstrated no association with prostate cancer, occurred in >90% of the simulated studies. On average, 36.4% of biosamples were saved from unnecessary genotyping. In contrast, for GSTT1, which demonstrated a positive association, inappropriate termination occurred in only 6.6%. GSM may provide significant cost and sample savings in molecular epidemiology studies.
Full Text
The Full Text of this article is available as a PDF (75.7 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Kaaks R., van der Tweel I., van Noord P. A., Riboli E. Efficient use of biological banks for biochemical epidemiology: exploratory hypothesis testing by means of a sequential t-test. Epidemiology. 1994 Jul;5(4):429–438. doi: 10.1097/00001648-199407000-00009. [DOI] [PubMed] [Google Scholar]
- O'Brien P. C., Fleming T. R. A multiple testing procedure for clinical trials. Biometrics. 1979 Sep;35(3):549–556. [PubMed] [Google Scholar]
- O'Neill R. T., Anello C. Case-control studies: a sequential approach. Am J Epidemiol. 1978 Nov;108(5):415–424. doi: 10.1093/oxfordjournals.aje.a112639. [DOI] [PubMed] [Google Scholar]
- Pasternak B. S., Shore R. E. Group sequential methods for cohort and case-control studies. J Chronic Dis. 1980;33(6):365–373. doi: 10.1016/0021-9681(80)90046-6. [DOI] [PubMed] [Google Scholar]
- Pocock S. J. Interim analyses for randomized clinical trials: the group sequential approach. Biometrics. 1982 Mar;38(1):153–162. [PubMed] [Google Scholar]
- Rebbeck T. R., Walker A. H., Jaffe J. M., White D. L., Wein A. J., Malkowicz S. B. Glutathione S-transferase-mu (GSTM1) and -theta (GSTT1) genotypes in the etiology of prostate cancer. Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 1):283–287. [PubMed] [Google Scholar]
- Satagopan Jaya M., Verbel David A., Venkatraman E. S., Offit Kenneth E., Begg Colin B. Two-stage designs for gene-disease association studies. Biometrics. 2002 Mar;58(1):163–170. doi: 10.1111/j.0006-341x.2002.00163.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schoenfeld D. A. A simple algorithm for designing group sequential clinical trials. Biometrics. 2001 Sep;57(3):972–974. doi: 10.1111/j.0006-341x.2001.00972.x. [DOI] [PubMed] [Google Scholar]
- Van der Tweel I., van Noord P. A. Sequential analysis of matched dichotomous data from prospective case-control studies. Stat Med. 2000 Dec 30;19(24):3449–3464. doi: 10.1002/1097-0258(20001230)19:24<3449::aid-sim648>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
- Whitehead J. A unified theory for sequential clinical trials. Stat Med. 1999 Sep 15;18(17-18):2271–2286. doi: 10.1002/(sici)1097-0258(19990915/30)18:17/18<2271::aid-sim254>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]